Skip to main content

Editorial [Hot Topic: Essential Fatty Acids (Guest Editor: Undurti N. Das)]

Buy Article:

$55.00 plus tax (Refund Policy)

This special issue of Current Pharmaceutical Biotechnology deals with an exciting topic: &ldquoEssential Fatty Acids” and their implications for human health.

Essential fatty acids (EFAs) are the main constituent of the phospholipid component of all cell membranes in the human body. EFAs, as it name implies, are essential for human survival but cannot be synthesized by the human body and hence, have to be obtained in our diet. The two EFAs are linoleic acid (LA) and -linolenic acid (ALA). Both LA and ALA form precursors to several of their long chain metabolites. Some of the important molecules that are formed from EFAs and their long-chain metabolites include: various eicosanoids, lipoxins, resolvins, and protectins. These molecules have several important actions on vascular tissue, platelets, leukocytes, macrophages, bronchial smooth muscle, myocardium, kidney, brain, and other cells and tissues in the body. Depending on the local tissue concentration and the type of metabolite formed from EFAs, they can have useful and harmful actions. For instance, excess formation of leukotrienes may produce inflammation, bronchospasm and thus may cause bronchial asthma. On the other hand, formation of appropriate amounts of lipoxins and resolvins may help in the resolution of inflammation and healing of wounds. In addition, EFAs may interact with nitric oxide and form nitrolipids that have potent biological actions. EFAs and their metabolites seem to have an important role in brain growth and development and memory formation and consolidation, participate in a variety of physiological and pathological processes.

In this issue, the metabolism, actions and uses of EFAs and their metabolites has been outlined by various authors. I hope that the topics discussed will be useful to many of the readers.

No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Research Article

Affiliations: UND Life Sciences 13800 Fairhill Road, #321Shaker Heights OH 44120 USA.

Publication date: 2006-12-01

More about this publication?
  • Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more